Benefit-risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373). Fix J, Christopher Mast T, Smith K, Baker N, et al. Vaccine 2024 Mar 16:S0264-410X(24)00323-2. doi: 10.1016/j.vaccine.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Fix J, Christopher Mast T, Smith K, Baker N, et al. Benefit-risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373). Vaccine 2024 Mar 16:S0264-410X(24)00323-2. doi: 10.1016/j.vaccine.2024.
PMID: 38494410